Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
22.6M
-
Shares change
-
+622K
-
Total reported value, excl. options
-
$384M
-
Value change
-
+$11.5M
-
Put/Call ratio
-
0.45
-
Number of buys
-
55
-
Number of sells
-
-51
-
Price
-
$16.96
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q4 2022
138 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q4 2022.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.6M shares
of 27.1M outstanding shares and own 83.42% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (4.24M shares), STATE STREET CORP (2.26M shares), ARK Investment Management LLC (2.01M shares), BlackRock Inc. (1.88M shares), VANGUARD GROUP INC (1.45M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.45M shares), Nikko Asset Management Americas, Inc. (1.45M shares), Balyasny Asset Management LLC (1M shares), FMR LLC (910K shares), and Woodline Partners LP (752K shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.